Intervention

Thoracic surgery

ClinicalTrials.gov intervention label

Clinical trials3

Recruiting1

Common conditions5

Lead sponsors shown3

Clinical trials

3 shown

Neoadjuvant IBI308, Bevacizumab, Plus Pemetrexed and Carboplatin Followed by Surgery in Unresectable Stage III NSCLCNCT03872661 · 2019-03-01

National Register Studies in Thoracic SurgeryNCT03567538 · 2018-01-01

ACTIVE_NOT_RECRUITING

Chronic Pain Following Thoracic SurgeryNCT01144845 · 2010-04-01

Common conditions

Lung Cancer1 Lung Cancer Stage III1 Pain, Postoperative1 Pulmonary Metastasis1 Surgery1

Leading sponsors

Karolinska University Hospital1 Sun Yat-sen University1 University of Aarhus1

Trial status mix

ACTIVE_NOT_RECRUITING1

COMPLETED1

RECRUITING1

Phase mix

PHASE21

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.